Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Zhang, Lingmin ^a   Wang, Ning ^a   Zhou, Suna ^a   Ye, Wenguang ^b   Jing, Guixia ^a   Zhang, Mingxin ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gallbladder cancer; Invasion; NF E2 related factor 2 (Nrf2); Proliferation; Propofol

Indexed keywords

MESSENGER RNA; PROPOFOL; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR NRF2;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; GALLBLADDER CANCER; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; NEOPLASM INVASIVENESS; NF-E2-RELATED FACTOR 2; PROPOFOL;

EID: 84865308060     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-66     Document Type: Article

References (22)

1. Propofol: therapeutic indications and side-effects. Marik PE, Curr Pharm Des 2004 10 3639 3649 10.2174/1381612043382846 15579060
2. Propofol: a review of its non-anaesthetic effects. Vasileiou I, Xanthos T, Koudouna E, Perrea D, Klonaris C, Katsargyris A, Papadimitriou L, Eur J Pharmacol 2009 605 1 8 10.1016/j.ejphar.2009.01.007 19248246
3. Propofol attenuation of renal ischemia/reperfusion injury involves heme oxygenase-1. Wang HH, Zhou HY, Chen CC, Zhang XL, Cheng G, Acta Pharmacol Sin 2007 28 1175 1180 10.1111/j.1745-7254.2007.00566.x 17640480
4. Propofol attenuation of hydrogen peroxide-mediated oxidative stress and apoptosis in cultured cardiomyocytes involves haeme oxygenase-1. Xu JJ, Wang YL, Eur J Anaesthesiol 2008 25 395 402 10.1017/S0265021508003542 18289444
5. Regulatory role of anesthetics on heme oxygenase-1. Hoetzel A, Schmidt R, Curr Drug Targets 2010 11 1495 1503 20704551
6. Propofol upregulates heme oxygenase-1 through activation of ERKs in human umbilical vein endothelial cells under oxidative stress conditions. Liang C, Xue Z, Wang H, Li P, J Neurosurg Anesthesiol 2011 23 229 235 10.1097/ANA.0b013e31821c007f 21593686
7. Heme oxygenase-1 in tumors: is it a false friend? Jozkowicz A, Was H, Dulak J, Antioxid Redox Signal 2007 9 2099 2117 10.1089/ars.2007.1659 17822372
8. Heme oxygenase-1 in tumor biology and therapy. Was H, Dulak J, Jozkowicz A, Curr Drug Targets 2010 11 1551 1570 20704546
9. Propofol-induced calcium signalling and actin reorganization within breast carcinoma cells. Garib V, Lang K, Niggemann B, Zänker KS, Brandt L, Dittmar T, Eur J Anaesthesiol 2005 22 609 615 10.1017/S026502150500102X 16119598
10. Intravenous anesthetic, propofol inhibits invasion of cancer cells. Mammoto T, Mukai M, Mammoto A, Yamanaka Y, Hayashi Y, Mashimo T, Kishi Y, Nakamura H, Cancer Lett 2002 184 165 170 10.1016/S0304-3835(02)00210-0 12127688
11. GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells. Miao Y, Zhang Y, Wan H, Chen L, Wang F, Biomed Pharmacother 2010 64 583 588 10.1016/j.biopha.2010.03.006 20888181
12. Intraoperative modulation of alveolar macrophage function during isoflurane and propofol anesthesia. Kotani N, Hashimoto H, Sessler DI, Kikuchi A, Suzuki A, Takahashi S, Muraoka M, Matsuki A, Anesthesiology 1998 89 1125 1132 10.1097/00000542-199811000-00012 9822000
13. Enhancement of antitumor immunity after propofol treatment in mice. Kushida A, Inada T, Shingu K, Immunopharmacol Immunotoxicol 2007 29 477 486 10.1080/08923970701675085 18075859
14. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S, Anesth Analg 2003 97 1331 1339 14570648
15. The cytoprotective role of the Keap1-Nrf2 pathway. Baird L, Dinkova-Kostova AT, Arch Toxicol 2011 85 241 272 10.1007/s00204-011-0674-5 21365312
16. Role of Nrf2-mediated heme oxygenase-1 upregulation in adaptive survival response to nitrosative stress. Surh YJ, Kundu JK, Li MH, Na HK, Cha YN, Arch Pharm Res 2009 32 1163 1176 10.1007/s12272-009-1807-8 19727608
17. Dual roles of Nrf2 in cancer. Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD, Pharmacol Res 2008 58 262 270 10.1016/j.phrs.2008.09.003 18838122
18. Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathological features and survival. Wang J, Zhang M, Zhang L, Cai H, Zhou S, Zhang J, Wang Y, J Surg Res 2010 164 99 e105 10.1016/j.jss.2010.05.058 20828733
19. Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)). Method. Livak KJ, Schmittgen TD, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609
20. Drugs of anaesthesia and cancer. Santamaria LB, Schifilliti D, La Torre D, Fodale V, Surg Oncol 2010 19 63 81 10.1016/j.suronc.2009.03.007 19394815
21. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Moi P, Chan K, Asunis I, Cao A, Kan YW, Proc Natl Acad Sci USA 1994 91 9926 9930 10.1073/pnas.91.21.9926 7937919
22. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Zhang DD, Drug Metab Rev 2006 38 769 789 10.1080/03602530600971974 17145701